GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (TSE:4519) » Definitions » Cyclically Adjusted PB Ratio

Chugai Pharmaceutical Co (TSE:4519) Cyclically Adjusted PB Ratio : 8.04 (As of May. 24, 2024)


View and export this data going back to 1956. Start your Free Trial

What is Chugai Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-05-24), Chugai Pharmaceutical Co's current share price is 円4748.00. Chugai Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was 円590.80. Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 8.04.

The historical rank and industry rank for Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:4519' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.33   Med: 7.94   Max: 15.27
Current: 8.47

During the past years, Chugai Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 15.27. The lowest was 4.33. And the median was 7.94.

TSE:4519's Cyclically Adjusted PB Ratio is ranked worse than
91.99% of 687 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs TSE:4519: 8.47

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Chugai Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2024 was 円997.974. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円590.80 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Chugai Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.94 13.80 8.53 6.68 9.31

Chugai Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.30 7.62 8.32 9.31 9.76

Competitive Comparison of Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Chugai Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=4748.00/590.8
=8.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chugai Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Chugai Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=997.974/107.2000*107.2000
=997.974

Current CPI (Mar. 2024) = 107.2000.

Chugai Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 357.596 98.000 391.166
201409 356.373 98.500 387.850
201412 364.301 97.900 398.908
201503 362.881 97.900 397.353
201506 374.356 98.400 407.835
201509 375.191 98.500 408.330
201512 382.056 98.100 417.496
201603 377.676 97.900 413.553
201606 383.843 98.100 419.449
201609 384.857 98.000 420.986
201612 393.891 98.400 429.117
201703 394.799 98.100 431.422
201706 407.391 98.500 443.374
201709 411.137 98.800 446.092
201712 421.820 99.400 454.921
201803 432.921 99.200 467.834
201806 445.748 99.200 481.695
201809 450.505 99.900 483.425
201812 460.421 99.700 495.056
201903 463.223 99.700 498.069
201906 482.533 99.800 518.312
201909 495.307 100.100 530.439
201912 519.908 100.500 554.569
202003 519.989 100.300 555.761
202006 551.539 99.900 591.842
202009 563.306 99.900 604.469
202012 596.156 99.300 643.584
202103 597.741 99.900 641.420
202106 639.989 99.500 689.516
202109 663.464 100.100 710.523
202112 722.497 100.100 773.743
202203 754.421 101.100 799.940
202206 795.064 101.800 837.238
202209 795.846 103.100 827.495
202212 866.247 104.100 892.043
202303 873.871 104.400 897.308
202306 920.334 105.200 937.831
202309 933.512 106.200 942.302
202312 988.008 106.800 991.708
202403 997.974 107.200 997.974

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Chugai Pharmaceutical Co  (TSE:4519) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Chugai Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chugai Pharmaceutical Co (TSE:4519) Business Description

Traded in Other Exchanges
Address
1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding Ltd, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and COVID-19.

Chugai Pharmaceutical Co (TSE:4519) Headlines

No Headlines